Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

Biogen Idec and MAKScientific enter MS agreement

March 16, 2012

Almirall attains new marketing rights to Sativex

March 16, 2012

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

Horizon Discovery and RFUMS to develop human cellular CF model

March 16, 2012

BioFocus, Argenta and AstraZeneca enter new research agreement

March 15, 2012

Epistem and GlaxoSmithKline enter biomarker collaboration

March 14, 2012

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

March 13, 2012

Amorfix announces new technology acquisition

March 13, 2012

OPKO Health attains global license to novel Parkinson's disease candidate

March 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...